Terms: = Gastric cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Diagnosis
257 results:
1. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
[TBL] [Abstract] [Full Text] [Related]
2. Novel metabolic biomarker for early detection and diagnosis to the patients with gastric cardia adenocarcinoma.
Wei MX; Yang Z; Wang PP; Zhao XK; Song X; Xu RH; Hu JF; Zhong K; Lei LL; Han WL; Yang MM; Zhou FY; Han XN; Fan ZM; Li J; Wang R; Li B; Wang LD
Cancer Med; 2024 Mar; 13(5):e7015. PubMed ID: 38491808
[TBL] [Abstract] [Full Text] [Related]
3. The role of mir96 in predicting CTC status and prognostic evaluation in gastric cancer patients.
Zheng Q; Ge H
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):264-274. PubMed ID: 38430012
[TBL] [Abstract] [Full Text] [Related]
4. A case report of carcinoma of the papilla of Vater associated with a hyperplasia-dysplasia-carcinoma sequence by pancreaticobiliary maljunction.
Korai T; Kimura Y; Watanabe K; Low SK; Imamura M; Nagayama M; Kukita K; Murakami T; Kato T; Kondo Y; Kyuno D; Sugawara T; Murota A; Kawakami Y; Masaki Y; Nakase H; Takemasa I
World J Surg Oncol; 2024 Feb; 22(1):63. PubMed ID: 38389074
[TBL] [Abstract] [Full Text] [Related]
5. Leptomeningeal carcinomatosis and brain metastases in gastroesophageal carcinoma: a real-world analysis of clinical and pathologic characteristics and outcomes.
Baccili Cury Megid T; Baskurt Z; Ma LX; Barron CC; Farooq A; Saltiel MP; Wang X; Bach Y; Ayoama H; Jang RW; Chen E; Veit-Haibach P; Wang B; Kalimuthu S; Cotton J; Wong R; Mesci A; Elimova E
J Neurooncol; 2024 Mar; 167(1):111-122. PubMed ID: 38372902
[TBL] [Abstract] [Full Text] [Related]
6. miRNA-449c-5p regulates the JAK-STAT pathway in inhibiting cell proliferation and invasion in human breast cancer cells by targeting erbb2.
Li L; Zhang Y; Yang K; Liu W; Zhou Z; Xu Y
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1974. PubMed ID: 38351535
[TBL] [Abstract] [Full Text] [Related]
7. [A Case of her2-Positive Unresectable Advanced gastric cancer Showing Long-Term Complete Response Treated by Only Chemotherapy].
Shirasaki Y; Wada N; Takachi K; Fujiwara M; Fukuda N; Matsuura Y; Munakata K; Takiuchi D; Hama N; Ota H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1887-1888. PubMed ID: 38303241
[TBL] [Abstract] [Full Text] [Related]
8. [A Case of Unresectable Advanced gastric cancer Successfully Treated with Conversion Surgery].
Yabe N; Takenoya T; Oto I; Harada Y; Kondo A; Ogiso M; Maeda H; Asada Y; Sako H; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1721-1723. PubMed ID: 38303185
[TBL] [Abstract] [Full Text] [Related]
9. [A Case of Recurrent gastric cancer with Long-Term Control via Two Resections and Multidisciplinary Treatment Including Nivolumab].
Bungo M; Takeno A; Hirao M; Hamakawa T; Yamamoto M; Matsui Y; Tokuyama S; Toshiyama R; Kawai K; Takahashi Y; Sakai K; Doi T; Goto K; Kato T; Takami K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1715-1717. PubMed ID: 38303183
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Curative Resection of the Local Advanced gastric cancer after SOX plus Nivolumab Chemotherapy, and the Pathological diagnosis Was Complete Response].
Harada K; Fukunaga K; Kashimoto K; Yamaguchi A
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1712-1714. PubMed ID: 38303182
[TBL] [Abstract] [Full Text] [Related]
11. [neuroendocrine Carcinoma of the Non-Ampullary Duodenum-A Case Report].
Tsukamoto T; Edagawa E; Togano S; Hori T; Tsujio G; Kunimoto T; Kaizaki R; Inoue T; Takatsuka S; Fukushima H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1700-1702. PubMed ID: 38303178
[TBL] [Abstract] [Full Text] [Related]
12. [A Case of Conversion Surgery after SOX plus Nivolumab for Unresectable Advanced gastric cancer].
Sato T; Kawaoka T; Xaolin Y; Matsukuma S; Tokunou K; Yamamoto S
Gan To Kagaku Ryoho; 2024 Jan; 51(1):75-77. PubMed ID: 38247097
[TBL] [Abstract] [Full Text] [Related]
13. Exosomal miRNAs from neutrophils act as accurate biomarkers for gastric cancer diagnosis.
Yu D; Zhang J; Wang M; Ji R; Qian H; Xu W; Zhang H; Gu J; Zhang X
Clin Chim Acta; 2024 Feb; 554():117773. PubMed ID: 38199579
[TBL] [Abstract] [Full Text] [Related]
14. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.
Wang FH; Zhang XT; Tang L; Wu Q; Cai MY; Li YF; Qu XJ; Qiu H; Zhang YJ; Ying JE; Zhang J; Sun LY; Lin RB; Wang C; Liu H; Qiu MZ; Guan WL; Rao SX; Ji JF; Xin Y; Sheng WQ; Xu HM; Zhou ZW; Zhou AP; Jin J; Yuan XL; Bi F; Liu TS; Liang H; Zhang YQ; Li GX; Liang J; Liu BR; Shen L; Li J; Xu RH
Cancer Commun (Lond); 2024 Jan; 44(1):127-172. PubMed ID: 38160327
[TBL] [Abstract] [Full Text] [Related]
15. Redox probe-free electrochemical immunosensor utilizing electropolymerized melamine on reduced graphene oxide for the point-of-care diagnosis of gastric cancer.
Kanagavalli P; Eissa S
Talanta; 2024 Apr; 270():125549. PubMed ID: 38157735
[TBL] [Abstract] [Full Text] [Related]
16. gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy.
Wang B; Zhu Y; Wang S; Li Z; Wang L; Rao W; Cheng N; Chen R; Ying J; Xue L
Gastric Cancer; 2024 Jan; 27(1):86-101. PubMed ID: 38019350
[TBL] [Abstract] [Full Text] [Related]
17. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases.
Yang X; Wu Y; Wang A; Ma X; Zhou K; Ji K; Ji X; Zhang J; Wu X; Li Z; Bu Z
J Pathol Clin Res; 2024 Jan; 10(1):e343. PubMed ID: 37974386
[TBL] [Abstract] [Full Text] [Related]
18. Targeting erbb2/her2 genetic alterations: an expanding therapeutic opportunity in gastrointestinal cancers.
Zheng-Lin B; Graham RP; Bekaii-Saab TS
Chin Clin Oncol; 2023 Oct; 12(5):55. PubMed ID: 37964543
[TBL] [Abstract] [Full Text] [Related]
19. Current and Emerging Role of Monoclonal Antibody-Based First-Line Treatment in Advanced Gastro-Esophageal and gastric cancer.
Désilets A; Elkhoury R; Gebai A; Tehfe M
Curr Oncol; 2023 Oct; 30(10):9304-9316. PubMed ID: 37887572
[TBL] [Abstract] [Full Text] [Related]
20. What Therapeutic Biomarkers in Gastro-Esophageal Junction and gastric cancer Should a Pathologist Know About?
Kumarasinghe MP; Houghton D; Allanson BM; Price TJ
Surg Pathol Clin; 2023 Dec; 16(4):659-672. PubMed ID: 37863558
[TBL] [Abstract] [Full Text] [Related]
[Next]
